GB9607993D0 - Novel compounds - Google Patents

Novel compounds

Info

Publication number
GB9607993D0
GB9607993D0 GBGB9607993.4A GB9607993A GB9607993D0 GB 9607993 D0 GB9607993 D0 GB 9607993D0 GB 9607993 A GB9607993 A GB 9607993A GB 9607993 D0 GB9607993 D0 GB 9607993D0
Authority
GB
United Kingdom
Prior art keywords
novel compounds
novel
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
GBGB9607993.4A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Beecham Ltd
Original Assignee
SmithKline Beecham Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SmithKline Beecham Ltd filed Critical SmithKline Beecham Ltd
Priority to GBGB9607993.4A priority Critical patent/GB9607993D0/en
Publication of GB9607993D0 publication Critical patent/GB9607993D0/en
Priority to PCT/US1997/006876 priority patent/WO1997038722A1/en
Priority to PCT/US1997/006877 priority patent/WO1997039017A1/en
Priority to PCT/US1997/006634 priority patent/WO1997038717A1/en
Priority to EP97921361A priority patent/EP0904281A4/en
Priority to EP97921302A priority patent/EP0904280A4/en
Priority to EP97922434A priority patent/EP0909181A4/en
Priority to JP09537450A priority patent/JP2000509975A/ja
Priority to JP09537430A priority patent/JP2000510688A/ja
Priority to US08/844,154 priority patent/US5827708A/en
Priority to EP97918806A priority patent/EP0904104A4/en
Priority to US08/843,521 priority patent/US5753479A/en
Priority to JP9537449A priority patent/JP2000509263A/ja
Priority to US08/844,055 priority patent/US5747313A/en
Priority to JP9537451A priority patent/JP2000509264A/ja
Priority to PCT/US1997/006875 priority patent/WO1997039022A1/en
Priority to PCT/US1997/006879 priority patent/WO1997038719A1/en
Priority to PCT/US1997/006638 priority patent/WO1997039014A1/en
Priority to US08/844,280 priority patent/US5747315A/en
Priority to JP09537452A priority patent/JP2000515366A/ja
Priority to EP97923452A priority patent/EP0951469A1/en
Priority to EP97918764A priority patent/EP0894006A4/en
Priority to JP09537428A priority patent/JP2000515724A/ja
Priority to US08/844,086 priority patent/US5866390A/en
Priority to US08/902,585 priority patent/US5834276A/en
Priority to US08/953,041 priority patent/US5871989A/en
Priority to US09/006,849 priority patent/US6071731A/en
Priority to US09/012,871 priority patent/US6200787B1/en
Priority to US09/018,211 priority patent/US6048716A/en
Priority to US09/093,134 priority patent/US6040162A/en
Priority to US09/126,192 priority patent/US6040163A/en
Priority to US09/159,417 priority patent/US6162625A/en
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/93—Ligases (6)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/315—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/315—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
    • C07K14/3153—Streptokinase
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/315—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
    • C07K14/3156—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci from Streptococcus pneumoniae (Pneumococcus)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911—Bacteria
    • G01N33/56944—Streptococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Urology & Nephrology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microbiology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Hematology (AREA)
  • Cell Biology (AREA)
  • Pathology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • General Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
GBGB9607993.4A 1996-04-18 1996-04-18 Novel compounds Pending GB9607993D0 (en)

Priority Applications (32)

Application Number Priority Date Filing Date Title
GBGB9607993.4A GB9607993D0 (en) 1996-04-18 1996-04-18 Novel compounds
US08/844,086 US5866390A (en) 1996-04-18 1997-04-18 Leucyl tRNA synthetase polynucleotides of streptococcus
JP9537451A JP2000509264A (ja) 1996-04-18 1997-04-18 ストレプトコッカス・ニューモニアエのヒスチジルｔＲＮＡシンセターゼ
PCT/US1997/006875 WO1997039022A1 (en) 1996-04-18 1997-04-18 Novel compounds
PCT/US1997/006634 WO1997038717A1 (en) 1996-04-18 1997-04-18 Novel compounds
EP97921361A EP0904281A4 (en) 1996-04-18 1997-04-18 HISTIDYL tRNA SYNTHETASE FROM STREPTOCOCCUS PNEUMONIAE
EP97921302A EP0904280A4 (en) 1996-04-18 1997-04-18 ASPARTYL tRNA SYNTHETASE OF STREPTOCOCCUS PNEUMONIAE
EP97922434A EP0909181A4 (en) 1996-04-18 1997-04-18 NEW COMPOUNDS
JP09537450A JP2000509975A (ja) 1996-04-18 1997-04-18 新規化合物
JP09537430A JP2000510688A (ja) 1996-04-18 1997-04-18 ストレプトコッカス・ニューモニアエのアスパルチルｔＲＮＡシンセターゼ
PCT/US1997/006638 WO1997039014A1 (en) 1996-04-18 1997-04-18 STREPTOCOCCUS PNEUMONIAE ASPARTYL tRNA SYNTHETASE
EP97918806A EP0904104A4 (en) 1996-04-18 1997-04-18 NEW CONNECTIONS
US08/843,521 US5753479A (en) 1996-04-18 1997-04-18 Phenylalanyl tRNA synthetase polynucleotides of streptococcus
JP9537449A JP2000509263A (ja) 1996-04-18 1997-04-18 新規化合物
US08/844,055 US5747313A (en) 1996-04-18 1997-04-18 DNA encoding histidyl tRNA synthetase from Streptococcus pneumoniae
PCT/US1997/006876 WO1997038722A1 (en) 1996-04-18 1997-04-18 Novel compounds
PCT/US1997/006879 WO1997038719A1 (en) 1996-04-18 1997-04-18 Novel compounds
US08/844,280 US5747315A (en) 1996-04-18 1997-04-18 DNA encoding aspartyl tRNA synthetase from Streptococcus pneumoniae
US08/844,154 US5827708A (en) 1996-04-18 1997-04-18 Asparaginyl tRNA synthetase polynucleotides of Streptococcus
PCT/US1997/006877 WO1997039017A1 (en) 1996-04-18 1997-04-18 STREPTOCOCCUS PNEUMONIAE HISTIDYL tRNA SYNTHETASE
JP09537452A JP2000515366A (ja) 1996-04-18 1997-04-18 新規化合物
EP97923452A EP0951469A1 (en) 1996-04-18 1997-04-18 Novel compounds
EP97918764A EP0894006A4 (en) 1996-04-18 1997-04-18 NEW COMPOUNDS
JP09537428A JP2000515724A (ja) 1996-04-18 1997-04-18 新規化合物
US08/902,585 US5834276A (en) 1996-04-18 1997-07-29 Asparaginyl TRNA synthetase polynucleotides of streptococcus
US08/953,041 US5871989A (en) 1996-04-18 1997-10-17 Phenylalanyl tRNA synthetase alpha subunit polynucleotides from streptococcus pneumoniae
US09/006,849 US6071731A (en) 1996-04-18 1998-01-14 Histidyl tRNA synthetase from streptococcus pneumoniae
US09/012,871 US6200787B1 (en) 1996-04-18 1998-01-23 Phenylalanyl tRNA synthetase polypeptides from streptococcus pneumoniae
US09/018,211 US6048716A (en) 1996-04-18 1998-02-03 Leucyl tRNA synthetase from Streptococcus pneumoniae
US09/093,134 US6040162A (en) 1996-04-18 1998-06-08 Histidyl tRNA synthetase from Streptococcus pneumoniae
US09/126,192 US6040163A (en) 1996-04-18 1998-07-30 Asparaginyl tRNA synthetase from streptococcus pneumoniae
US09/159,417 US6162625A (en) 1996-04-18 1998-09-24 Phenylalanyl tRNA synthetase from streptococcus pneumoniae

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9607993.4A GB9607993D0 (en) 1996-04-18 1996-04-18 Novel compounds

Publications (1)

Publication Number Publication Date
GB9607993D0 true GB9607993D0 (en) 1996-06-19

Family

ID=10792237

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB9607993.4A Pending GB9607993D0 (en) 1996-04-18 1996-04-18 Novel compounds

Country Status (5)

Country Link
US (9) US5827708A (https=)
EP (6) EP0904281A4 (https=)
JP (6) JP2000509975A (https=)
GB (1) GB9607993D0 (https=)
WO (6) WO1997038717A1 (https=)

Families Citing this family (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5834276A (en) * 1996-04-18 1998-11-10 Smithkline Beecham Corporation Asparaginyl TRNA synthetase polynucleotides of streptococcus
US5795758A (en) * 1997-04-18 1998-08-18 Smithkline Beecham Corporation DNA encoding histidyl tRNA synthetase variant from Streptococcus pneumoniae
US5858720A (en) * 1997-07-23 1999-01-12 Smithkline Beecham Corporation Hiss
US5882892A (en) 1997-07-23 1999-03-16 Smithkline Beecham Corporation Asps
EP0916728A1 (en) * 1997-10-17 1999-05-19 Smithkline Beecham Corporation Phenyl alanyl tRNA synthetase [EC 6.1.1.20] alpha subunit family, pheS (alpha), from Streptococcus pneumoniae
NZ504669A (en) 1997-11-25 2002-11-26 Gen Hospital Corp Virulence-associated nucleic acid sequences and uses in identification of anti-virulence agents
WO1999061452A2 (en) * 1998-05-28 1999-12-02 Smithkline Beecham Corporation acpS
US6245539B1 (en) 1998-10-06 2001-06-12 Board Of Trustees Operating Michigan State University Human asparaginyl-tRNA synthetase DNA
WO2001040332A1 (en) 1999-11-29 2001-06-07 Daikin Industries, Ltd. Fluororesin material lowly permeable to liquid chemical
US7112716B2 (en) 2000-04-06 2006-09-26 The General Hospital Corporation Methods for screening and identifying host pathogen defense genes
WO2009152247A2 (en) 2008-06-11 2009-12-17 Atyr Pharma, Inc Thrombopoietic activity of tyrosyl-trna synthetase polypeptides
CN102159708B (zh) 2008-06-26 2016-08-31 Atyr医药公司 包含具有非常规生物活性的甘氨酰-tRNA合成酶的组合物和方法
EP2403864B1 (en) 2009-02-27 2015-08-12 Atyr Pharma, Inc. Polypeptide structural motifs associated with cell signaling activity
AU2010226726B8 (en) 2009-03-16 2014-08-14 Pangu Biopharma Limited Compositions and methods comprising histidyl-tRNA synthetase splice variants having non-canonical biological activities
US20100310576A1 (en) 2009-03-31 2010-12-09 Adams Ryan A COMPOSITIONS AND METHODS COMPRISING ASPARTYL-tRNA SYNTHETASES HAVING NON-CANONICAL BIOLOGICAL ACTIVITIES
US9127268B2 (en) 2009-12-11 2015-09-08 Atyr Pharma, Inc. Aminoacyl tRNA synthetases for modulating inflammation
US8828395B2 (en) 2009-12-11 2014-09-09 Atyr Pharma, Inc. Antibodies that bind tyrosyl-tRNA synthetases
CA2797093C (en) 2010-04-26 2019-10-29 Atyr Pharma, Inc. Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of cysteinyl-trna synthetase
AU2011248521B2 (en) 2010-04-27 2017-03-16 Pangu Biopharma Limited Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of threonyl tRNA synthetases
EP2563381B1 (en) 2010-04-27 2017-08-09 aTyr Pharma, Inc. Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of isoleucyl trna synthetases
CN103097524B (zh) 2010-04-28 2016-08-03 Atyr医药公司 与丙氨酰-tRNA合成酶的蛋白片段相关的治疗、诊断和抗体组合物的创新发现
EP2563383B1 (en) 2010-04-29 2017-03-01 Atyr Pharma, Inc. Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of valyl trna synthetases
CA2797374C (en) 2010-04-29 2021-02-16 Pangu Biopharma Limited Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of asparaginyl trna synthetases
ES2668207T3 (es) 2010-05-03 2018-05-17 Atyr Pharma, Inc. Descubrimiento innovador de composiciones terapéuticas, de diagnóstico y de anticuerpos relacionadas con fragmentos de proteínas de metionil-ARNt sintetasas
CN103096925A (zh) 2010-05-03 2013-05-08 Atyr医药公司 与精氨酰-tRNA合成酶的蛋白片段相关的治疗、诊断和抗体组合物的创新发现
AU2011248227B2 (en) 2010-05-03 2016-12-01 Pangu Biopharma Limited Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of phenylalanyl-alpha-tRNA synthetases
EP2566516B1 (en) 2010-05-03 2019-07-03 aTyr Pharma, Inc. Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of seryl-trna synthetases
JP6008844B2 (ja) 2010-05-04 2016-10-19 エータイアー ファーマ， インコーポレイテッド ｐ３８ＭＵＬＴＩ−ｔＲＮＡ合成酵素複合体のタンパク質フラグメントに関連した治療用、診断用および抗体組成物の革新的発見
CN103096909A (zh) 2010-05-04 2013-05-08 Atyr医药公司 与谷氨酰-脯氨酰-tRNA合成酶的蛋白片段相关的治疗、诊断和抗体组合物的创新发现
EP2568996B1 (en) 2010-05-14 2017-10-04 aTyr Pharma, Inc. Therapeutic, diagnostic, and antibody compositions related to protein fragments of phenylalanyl-beta-trna synthetases
US9034598B2 (en) 2010-05-17 2015-05-19 Atyr Pharma, Inc. Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of leucyl-tRNA synthetases
CN103096913B (zh) 2010-05-27 2017-07-18 Atyr 医药公司 与谷氨酰胺酰‑tRNA合成酶的蛋白片段相关的治疗、诊断和抗体组合物的创新发现
CA2800281C (en) 2010-06-01 2021-01-12 Atyr Pharma, Inc. Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of lysyl-trna synthetases
KR20130102534A (ko) 2010-07-12 2013-09-17 에이티와이알 파마, 인코포레이티드 히스티딜­trna 합성효소의 단백질 단편에 관련된 치료적, 진단적, 및 항체 조성물의 혁신적 발견
US8999321B2 (en) 2010-07-12 2015-04-07 Atyr Pharma, Inc. Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of glycyl-tRNA synthetases
AU2011289831C1 (en) 2010-07-12 2017-06-15 Pangu Biopharma Limited Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of glycyl-tRNA synthetases
KR20180059575A (ko) 2010-07-12 2018-06-04 에이티와이알 파마, 인코포레이티드 아스파르틸­trna 합성효소의 단백질 단편에 관련된 치료적, 진단적, 및 항체 조성물의 혁신적 발견
CN103108650A (zh) 2010-08-25 2013-05-15 Atyr医药公司 与酪氨酰-tRNA合成酶的蛋白片段相关的治疗、诊断和抗体组合物的创新发现
CN103118696B (zh) 2010-10-06 2020-02-14 Atyr 医药公司 与色氨酰-tRNA合成酶的蛋白片段相关的治疗、诊断和抗体组合物
US9714419B2 (en) 2011-08-09 2017-07-25 Atyr Pharma, Inc. PEGylated tyrosyl-tRNA synthetase polypeptides
WO2013086228A1 (en) 2011-12-06 2013-06-13 Atyr Pharma, Inc. Pegylated aspartyl-trna synthetase polypeptides
WO2013086216A1 (en) * 2011-12-06 2013-06-13 Atyr Pharma, Inc. Improved aspartyl-trna synthetases
CA2858613A1 (en) * 2011-12-29 2013-08-08 Atyr Pharma, Inc. Aspartyl-trna synthetase-fc conjugates
EP2814514B1 (en) 2012-02-16 2017-09-13 Atyr Pharma, Inc. Histidyl-trna synthetases for treating autoimmune and inflammatory diseases
ES2708565T3 (es) 2013-03-15 2019-04-10 Atyr Pharma Inc Conjugados de Fc-histidil-ARNt sintetasa
CA3060514A1 (en) 2017-04-20 2018-10-25 Atyr Pharma, Inc. Compositions and methods for treating lung inflammation
US11530413B2 (en) 2017-07-21 2022-12-20 Novartis Ag Compositions and methods to treat cancer

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU6958194A (en) * 1993-05-28 1994-12-20 Massachusetts Institute Of Technology Trna binding-dependent inhibition of microbial pathogen growth
WO1996033276A1 (en) * 1995-04-21 1996-10-24 Human Genome Sciences, Inc. NUCLEOTIDE SEQUENCE OF THE HAEMOPHILUS INFLUENZAE Rd GENOME, FRAGMENTS THEREOF, AND USES THEREOF
US6737248B2 (en) * 1996-01-05 2004-05-18 Human Genome Sciences, Inc. Staphylococcus aureus polynucleotides and sequences
WO1997026344A1 (en) * 1996-01-19 1997-07-24 Smithkline Beecham Plc ASPARTYL-tRNA SYNTHETASE OF STAPHYLOCOCCUS AUREUS
JPH11502425A (ja) * 1996-01-19 1999-03-02 スミスクライン・ビーチャム・パブリック・リミテッド・カンパニー スタフィロコッカス・アウレウスのアスパラギニルｔＲＮＡシンセターゼ
JP4469026B2 (ja) * 1996-10-31 2010-05-26 ヒューマン ジノーム サイエンシーズ，インコーポレイテッド Ｓｔｒｅｐｔｏｃｏｃｃｕｓ ｐｎｅｕｍｏｎｉａｅの抗原およびワクチン

Also Published As

Publication number Publication date
JP2000509264A (ja) 2000-07-25
US6048716A (en) 2000-04-11
US6040163A (en) 2000-03-21
WO1997038719A1 (en) 1997-10-23
EP0951469A4 (https=) 1999-11-03
EP0904104A1 (en) 1999-03-31
WO1997038722A1 (en) 1997-10-23
EP0894006A1 (en) 1999-02-03
US5827708A (en) 1998-10-27
WO1997039017A1 (en) 1997-10-23
EP0904281A4 (en) 2000-01-12
EP0904280A4 (en) 1999-10-20
US6200787B1 (en) 2001-03-13
EP0904104A4 (en) 1999-11-03
JP2000509975A (ja) 2000-08-08
EP0904280A1 (en) 1999-03-31
US5753479A (en) 1998-05-19
EP0909181A4 (en) 1999-11-03
WO1997038717A1 (en) 1997-10-23
EP0904281A1 (en) 1999-03-31
WO1997039014A1 (en) 1997-10-23
US5747313A (en) 1998-05-05
JP2000515366A (ja) 2000-11-21
EP0951469A1 (en) 1999-10-27
US5747315A (en) 1998-05-05
US6071731A (en) 2000-06-06
JP2000509263A (ja) 2000-07-25
JP2000510688A (ja) 2000-08-22
EP0894006A4 (en) 1999-11-24
WO1997039022A1 (en) 1997-10-23
EP0909181A1 (en) 1999-04-21
JP2000515724A (ja) 2000-11-28
US5866390A (en) 1999-02-02

Similar Documents

Publication Publication Date Title
EP0914330A4 (en) NEW TYPE COMPOUNDS
EP0961618A4 (en) NEW COMPOUNDS
GB9607993D0 (en) Novel compounds
GB9601067D0 (en) Novel compounds
EP0907375A4 (en) NEW COMPOUNDS
AP9701047A0 (en) Novel compounds
GB9605945D0 (en) Novel compounds
GB9600955D0 (en) Novel compounds
GB9604045D0 (en) Novel compounds
AP9701037A0 (en) Novel compounds
GB9605883D0 (en) Novel compounds
GB9605381D0 (en) Novel compounds
GB9601069D0 (en) Novel compounds
EP0954525A4 (en) NEW CONNECTIONS
GB9601068D0 (en) Novel compounds
GB9606208D0 (en) Novel compounds
GB9601066D0 (en) Novel compounds
GB9601099D0 (en) Novel compounds
GB9603655D0 (en) Novel compounds
GB9601096D0 (en) Novel compounds
GB9604598D0 (en) Novel compounds
GB9603689D0 (en) Novel compounds
GB9600048D0 (en) Novel compounds
GB9602679D0 (en) Novel compounds
GB9604574D0 (en) Novel compounds